Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells--potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation.

BACKGROUND Peroxisome proliferator-activated receptor gamma (PPARgamma) plays a role in the regulation of intestinal inflammation and is activated by both natural (polyunsaturated fatty acid; PUFAs) and synthetic (troglitazone) ligands. The fatty acid content of defined formula diets may play a role in mediating the antiinflammatory effect, but the mechanism is unclear. OBJECTIVE We evaluated to what extent the effect of PUFAs on intestinal inflammation is mediated via PPARgamma. DESIGN The human enterocyte-like cell line Caco-2 and human dendritic cells were stimulated by interleukin (IL) 1beta and lipoprotein polysaccharide, respectively, in the presence of PPARgamma agonists (troglitazone or PUFAs) or antagonist (GW9662). Five PUFAs were tested: alpha-linolenic acid (ALA), conjugated linoleic acid (CLA), docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and gamma-linolenic acid (GLA). Cytokine production was measured by enzyme-linked immunosorbent assay and PPARgamma, I-kappaB, and inducible nitric oxide synthase (iNOS) expression by Western blot. RESULTS In Caco-2 cells, IL-6 secretion was significantly decreased by troglitazone, DHA, EPA, and GLA. IL-8 production was significantly decreased by troglitazone, ALA, DHA, EPA, and GLA. PPARgamma expression was significantly increased by troglitazone, DHA, and EPA. iNOS expression was significantly decreased by troglitazone, DHA, and EPA. Troglitazone and PUFAs at 0.1 mumol/L tended to increase the expression of I-kappaB. Addition of GW9662 reversed the effect of troglitazone and PUFAs at 0.1 mumol/L on IL-8 production and decreased the expression of PPARgamma. EPA and DHA also modulated the dendritic cell response to lipoprotein polysaccharide. CONCLUSIONS The tested PUFAs exerted an antiinflammatory effect in vitro in both models. This effect of PUFAs in Caco-2 cells is similar to that of troglitazone on intestinal inflammation mediated by PPARgamma, and the potency of the antiinflammatory effect is linked to the number of double bonds.

[1]  R. Playford,et al.  NOD2 activity modulates the phenotype of LPS-stimulated dendritic cells to promote the development of T-helper type 2-like lymphocytes - Possible implications for NOD2-associated Crohn's disease. , 2007, Journal of Crohn's & colitis.

[2]  P. Kris-Etherton,et al.  Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. , 2007, The American journal of clinical nutrition.

[3]  L. Nagy,et al.  PPARγ, a Lipid‐Activated Transcription Factor as a Regulator of Dendritic Cell Function , 2006 .

[4]  X. Thuru,et al.  PPARγ as a new therapeutic target in inflammatory bowel diseases , 2006, Gut.

[5]  K. Weylandt,et al.  Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Y. Tomino,et al.  Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  Subrata Ghosh,et al.  Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease. , 2005, World journal of gastroenterology.

[8]  K. Morimura,et al.  Peroxisome proliferator activated receptor γ in colonic epithelial cells protects against experimental inflammatory bowel disease , 2005, Gut.

[9]  J. Chung,et al.  Eicosapentaenoic acid inhibits UV-induced MMP-1 expression in human dermal fibroblasts Published, JLR Papers in Press, June 1, 2005. DOI 10.1194/jlr.M500105-JLR200 , 2005, Journal of Lipid Research.

[10]  J. Glickman,et al.  Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Auwerx,et al.  Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ , 2005, The Journal of experimental medicine.

[12]  A. Sher,et al.  Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 , 2005, The Journal of experimental medicine.

[13]  M. Perretti,et al.  Controlling inflammation , 2005, The Journal of experimental medicine.

[14]  D. Straus,et al.  the Peroxisome Proliferator‐Activated Receptor &ggr; Ligand Rosiglitazone Delays the Onset of Inflammatory Bowel Disease in Mice With Interleukin 10 Deficiency , 2005, Inflammatory bowel diseases.

[15]  A. Nakajima,et al.  Intestinal Antiinflammatory Effects of Thiazolidenedione Peroxisome Proliferator‐Activated Receptor‐&ggr; Ligands on T Helper Type 1 Chemokine Regulation Include Nontranscriptional Control Mechanisms , 2005, Inflammatory bowel diseases.

[16]  Jifeng Zhang,et al.  Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor γ ligand , 2005 .

[17]  C. Moskaluk,et al.  Linkage to peroxisome proliferator-activated receptor-gamma in SAMP1/YitFc mice and in human Crohn's disease. , 2005, Gastroenterology.

[18]  B. P. Kota,et al.  An overview on biological mechanisms of PPARs. , 2005, Pharmacological research.

[19]  J. Bassaganya-Riera,et al.  Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease , 2004 .

[20]  P. Ducrotte,et al.  Glutamine and CXC chemokines IL-8, Mig, IP-10 and I-TAC in human intestinal epithelial cells. , 2004, Clinical nutrition.

[21]  P. Déchelotte,et al.  Cytokine-stimulated nitric oxide production and inducible NO-synthase mRNA level in human intestinal cells: lack of modulation by glutamine. , 2003, Clinical nutrition.

[22]  J. Furet,et al.  Docosahexaenoic acid membrane content and mRNA expression of acyl‐CoA oxidase and of peroxisome proliferator‐activated receptor‐δ are modulated in Y79 retinoblastoma cells differently by low and high doses of α‐linolenic acid , 2003, Journal of neuroscience research.

[23]  S. Nakagawa,et al.  A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. , 2003, Gastroenterology.

[24]  Johan Auwerx,et al.  Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis , 2003 .

[25]  N. Narayanan,et al.  Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. , 2003, Cancer research.

[26]  A. Munakata,et al.  Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized, controlled trial , 2003, European journal of gastroenterology & hepatology.

[27]  Dallas Jones,et al.  Emerging roles of PPARS in inflammation and immunity , 2002, Nature Reviews Immunology.

[28]  Y. Naito,et al.  Pioglitazone, a PPAR-γ ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-κB-cytokine cascade , 2002 .

[29]  C. Richart,et al.  Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial , 2002, Gut.

[30]  S. Ghosh,et al.  Anti-inflammatory effects of enteral diet components on Crohn's disease-affected tissues in vitro. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[31]  R. Rossetti,et al.  Oral Administration of Gammalinolenic Acid, an Unsaturated Fatty Acid with Anti-inflammatory Properties, Modulates Interleukin-1β Production by Human Monocytes , 2002, Journal of Clinical Immunology.

[32]  A. Hichami,et al.  Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells. , 2001, Journal of lipid research.

[33]  E. Furth,et al.  An open-label trial of the PPARγ ligand rosiglitazone for active ulcerative colitis , 2001, American Journal of Gastroenterology.

[34]  S. Ghosh,et al.  Modification of enteral diets in inflammatory bowel disease , 2001, Proceedings of the Nutrition Society.

[35]  J. Auwerx,et al.  Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator–Activated Receptor γ (Pparγ) Heterodimer , 2001, The Journal of experimental medicine.

[36]  S. Wright,et al.  Production of matrix metalloproteinase-9 in CaCO-2 cells in response to inflammatory stimuli. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[37]  G. Ghosh,et al.  15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway , 2000 .

[38]  T. Willson,et al.  The PPARs: from orphan receptors to drug discovery. , 2000, Journal of medicinal chemistry.

[39]  M. Lazar,et al.  A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. , 1999, The Journal of clinical investigation.

[40]  Subrata Ghosh,et al.  5 Crohn's disease: nutrition and nutritional therapy , 1998 .

[41]  Peter J. Brown,et al.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .

[42]  M. Comalada,et al.  Biochemical and Molecular Actions of Nutrients Dietary Olive Oil Supplemented with Fish Oil , Rich in EPA and DHA ( n-3 ) Polyunsaturated Fatty Acids , Attenuates Colonic Inflammation in Rats with DSS-Induced Colitis 1 , 2005 .

[43]  S. Pettersson,et al.  Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA , 2004, Nature Immunology.